Protease Inhibitor Drugs: The Expanding Cathepsin Inhibitor Market
Protease inhibitor drugs have become a cornerstone of modern pharmacology, with cathepsin inhibitors emerging as a particularly promising class for treating a range of diseases. Protease inhibitor drugs targeting cathepsins are designed to selectively block these enzymes, which are implicated in cancer progression, autoimmune inflammation, and neurodegenerative processes. The global...
0 Comentários 0 Compartilhamentos 3 Visualizações 0 Anterior